17-8316081-G-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_173728.4(ARHGEF15):c.1637G>C(p.Arg546Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00125 in 1,602,988 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00093 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0013 ( 2 hom. )
Consequence
ARHGEF15
NM_173728.4 missense
NM_173728.4 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 4.58
Genes affected
ARHGEF15 (HGNC:15590): (Rho guanine nucleotide exchange factor 15) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein-coupled receptors. This gene encodes a protein that functions as a specific guanine nucleotide exchange factor for RhoA. It also interacts with ephrin A4 in vascular smooth muscle cells. Two alternatively spliced transcripts variants that encode the same protein have been found for this gene. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.076511025).
BP6
Variant 17-8316081-G-C is Benign according to our data. Variant chr17-8316081-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 461427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF15 | NM_173728.4 | c.1637G>C | p.Arg546Pro | missense_variant | Exon 9 of 16 | ENST00000361926.8 | NP_776089.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF15 | ENST00000361926.8 | c.1637G>C | p.Arg546Pro | missense_variant | Exon 9 of 16 | 1 | NM_173728.4 | ENSP00000355026.3 | ||
ARHGEF15 | ENST00000421050.2 | c.1637G>C | p.Arg546Pro | missense_variant | Exon 9 of 16 | 1 | ENSP00000412505.1 | |||
ARHGEF15 | ENST00000647883.1 | c.1100G>C | p.Arg367Pro | missense_variant | Exon 6 of 13 | ENSP00000498197.1 |
Frequencies
GnomAD3 genomes AF: 0.000933 AC: 142AN: 152182Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
142
AN:
152182
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000712 AC: 167AN: 234688Hom.: 0 AF XY: 0.000752 AC XY: 97AN XY: 128918
GnomAD3 exomes
AF:
AC:
167
AN:
234688
Hom.:
AF XY:
AC XY:
97
AN XY:
128918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00129 AC: 1865AN: 1450688Hom.: 2 Cov.: 33 AF XY: 0.00125 AC XY: 903AN XY: 721996
GnomAD4 exome
AF:
AC:
1865
AN:
1450688
Hom.:
Cov.:
33
AF XY:
AC XY:
903
AN XY:
721996
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000932 AC: 142AN: 152300Hom.: 0 Cov.: 31 AF XY: 0.000980 AC XY: 73AN XY: 74468
GnomAD4 genome
AF:
AC:
142
AN:
152300
Hom.:
Cov.:
31
AF XY:
AC XY:
73
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
10
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
83
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;.
REVEL
Uncertain
Sift
Benign
T;T;.
Sift4G
Uncertain
D;D;.
Polyphen
B;B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at